Bayer AG (BAYRY)
14.25
-0.09
(-0.63%)
USD |
OTCM |
Aug 26, 16:00
Bayer Price to Book Value : 1.656 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 1.656 |
| August 25, 2026 | 1.666 |
| August 24, 2026 | 1.640 |
| August 21, 2026 | 1.634 |
| August 20, 2026 | 1.640 |
| August 19, 2026 | 1.670 |
| August 18, 2026 | 1.640 |
| August 17, 2026 | 1.608 |
| August 14, 2026 | 1.608 |
| August 13, 2026 | 1.608 |
| August 12, 2026 | 1.616 |
| August 11, 2026 | 1.658 |
| August 10, 2026 | 1.650 |
| August 07, 2026 | 1.678 |
| August 06, 2026 | 1.664 |
| August 05, 2026 | 1.654 |
| August 04, 2026 | 1.624 |
| August 03, 2026 | 1.577 |
| July 31, 2026 | 1.614 |
| July 30, 2026 | 1.623 |
| July 29, 2026 | 1.585 |
| July 28, 2026 | 1.567 |
| July 27, 2026 | 1.556 |
| July 24, 2026 | 1.526 |
| July 23, 2026 | 1.526 |
| Date | Value |
|---|---|
| July 22, 2026 | 1.550 |
| July 21, 2026 | 1.580 |
| July 20, 2026 | 1.560 |
| July 17, 2026 | 1.603 |
| July 16, 2026 | 1.580 |
| July 15, 2026 | 1.584 |
| July 14, 2026 | 1.623 |
| July 13, 2026 | 1.645 |
| July 10, 2026 | 1.659 |
| July 09, 2026 | 1.678 |
| July 08, 2026 | 1.679 |
| July 07, 2026 | 1.674 |
| July 06, 2026 | 1.690 |
| July 02, 2026 | 1.764 |
| July 01, 2026 | 1.609 |
| June 30, 2026 | 1.592 |
| June 29, 2026 | 1.545 |
| June 26, 2026 | 1.573 |
| June 25, 2026 | 1.556 |
| June 24, 2026 | 1.330 |
| June 23, 2026 | 1.294 |
| June 22, 2026 | 1.278 |
| June 18, 2026 | 1.249 |
| June 17, 2026 | 1.266 |
| June 16, 2026 | 1.227 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 2.046 |
| Breakthrough Chemistry, Inc. | 4.474 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.348 |
| Carl Zeiss Meditec AG | 3.305 |
Price to Book Value Related Metrics
| PS Ratio | 1.058 |
| Price to Free Cash Flow | 75.80 |
| Price | 14.25 |
| Earnings Yield | -3.59% |
| Market Cap | 56.00B |
| Operating PE Ratio | 7.659 |
| Normalized PE Ratio | 28.85 |